Acrotech Biopharma Inc.
Clinical trials sponsored by Acrotech Biopharma Inc., explained in plain language.
-
New combo therapy aims to outperform standard chemo for rare blood cancer
Disease control Recruiting nowThis phase 3 study tests whether adding the drugs Beleodaq or Folotyn to standard chemotherapy (CHOP) helps people with newly diagnosed peripheral T-cell lymphoma live longer without their cancer getting worse. About 504 participants will be randomly assigned to one of three trea…
Phase: PHASE3 • Sponsor: Acrotech Biopharma Inc. • Aim: Disease control
Last updated May 17, 2026 04:33 UTC
-
New study seeks safer dosing for cancer drug in patients with liver issues
Knowledge-focused Recruiting nowThis study looks at how the body processes the cancer drug pralatrexate in people with advanced solid tumors or blood cancers who also have mild, moderate, or severe liver problems. Researchers will measure drug levels in the blood and track side effects to find the safest dose. …
Phase: PHASE1 • Sponsor: Acrotech Biopharma Inc. • Aim: Knowledge-focused
Last updated May 11, 2026 20:51 UTC